Old drug, new hope: testing a tapeworm medicine against childhood leukemia
NCT ID NCT05188170
Summary
This is an early safety study testing a drug called niclosamide, which is normally used to treat tapeworms, in combination with a standard chemotherapy (cytarabine) for children and young adults with acute myeloid leukemia (AML) that has come back or not responded to other treatments. The main goal is to find a safe dose and see if the combination causes severe side effects. Researchers will also check if the treatment helps reduce the amount of leukemia cells in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGPalo Alto, California, 94305, United States
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.